Free tool
IBB and PBE: how much do they overlap?
Enter any two ETFs or mutual funds to see how much of their portfolios overlap, using each fund's latest SEC holdings report.
Bottom line
Overlap between IBB and PBE
36% of their top holdings overlap by weight, with 12 securities in common among each fund's top 25. They share a meaningful core but differ in the rest of the portfolio. Note that IBB holds far more positions (254 vs 33), so it is broader beyond the top names.
| Holding | % of IBB | % of PBE |
|---|---|---|
| Vertex Pharmaceuticals, Inc. | 7.66% | 4.99% |
| Gilead Sciences, Inc. | 7.52% | 4.43% |
| Amgen, Inc. | 7.50% | 5.22% |
| Regeneron Pharmaceuticals, Inc. | 5.70% | 5.47% |
| Alnylam Pharmaceuticals, Inc. | 5.68% | 3.17% |
| Biogen, Inc. | 2.03% | 4.79% |
| United Therapeutics Corp. | 1.82% | 4.08% |
| Incyte Corp. | 1.62% | 3.06% |
| Illumina, Inc. | 1.41% | 3.51% |
| Neurocrine Biosciences, Inc. | 1.34% | 2.66% |
| Exelixis, Inc. | 1.07% | 2.64% |
| BioMarin Pharmaceutical, Inc. | 1.02% | 2.82% |
Source: SEC Form N-PORT (periods Sep 30, 2025 / Jul 31, 2026)
Popular overlap checks
| Pair | Overlap | |
|---|---|---|
| VOO vs VTI | 99% | Details |
| QQQ vs VGT | 57% | Details |
| SCHD vs VYM | 24% | Details |
| VOO vs QQQ | 68% | Details |
| VTI vs VXUS | 0% | Details |
| VUG vs QQQ | 69% | Details |
| JEPI vs SCHD | 2% | Details |
Source: SEC Form N-PORT; top-25 holdings, weight-normalized